Joel B. Nelson

21.7k total citations · 4 hit papers
188 papers, 10.8k citations indexed

About

Joel B. Nelson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Joel B. Nelson has authored 188 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pulmonary and Respiratory Medicine, 48 papers in Molecular Biology and 40 papers in Oncology. Recurrent topics in Joel B. Nelson's work include Prostate Cancer Treatment and Research (86 papers), Prostate Cancer Diagnosis and Treatment (49 papers) and Nitric Oxide and Endothelin Effects (23 papers). Joel B. Nelson is often cited by papers focused on Prostate Cancer Treatment and Research (86 papers), Prostate Cancer Diagnosis and Treatment (49 papers) and Nitric Oxide and Endothelin Effects (23 papers). Joel B. Nelson collaborates with scholars based in United States, Canada and China. Joel B. Nelson's co-authors include Susan L. Greenspan, Michael A. Carducci, Jianhua Luo, Yan Yu, Neil M. Resnick, Donald L. Trump, George K. Michalopoulos, Bruno Battistini, Anna Bagnato and Perry D. Nisen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Joel B. Nelson

185 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

2015 945 citations Joel B. Nelson, Anil V. Parwani et al. profile →
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

2017 583 citations Martin G. Sanda, Jeffrey A. Cadeddu et al. The Journal of Urology profile →
Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy

2004 574 citations Yan Yu, Joel B. Nelson et al. profile →
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options

2018 252 citations Martin G. Sanda, Jeffrey A. Cadeddu et al. The Journal of Urology profile →

Peers

Countries citing papers authored by Joel B. Nelson

Since Specialization

Citations

This map shows the geographic impact of Joel B. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel B. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel B. Nelson more than expected).

Fields of papers citing papers by Joel B. Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel B. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel B. Nelson. The network helps show where Joel B. Nelson may publish in the future.

Co-authorship network of co-authors of Joel B. Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of Joel B. Nelson. A scholar is included among the top collaborators of Joel B. Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel B. Nelson. Joel B. Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fusion Gene Detection in Prostate Cancer Samples Enhances the Prediction of Prostate Cancer Clinical Outcomes from Radical Prostatectomy through Machine Learning in a Multi-Institutional Analysis 2023 ·American Journal Of Pathology ·Yanping Yu, Silvia Liu, Bao‐Guo Ren, Joel B. Nelson, David F. Jarrard, James D. Brooks, George K. Michalopoulos, George C. Tseng, Jianhua Luo	5
2	Association of Routine Preoperative Frailty Assessment With 1-Year Postoperative Mortality 2023 ·JAMA Surgery ·Patrick R. Varley, (unknown), Andrew Bilderback, Mary Kay Wisniewski, Jason M. Johanning, Joel B. Nelson, Jonas T. Johnson, (unknown), Daniel E. Hall	33
3	System-Wide, Prospective Frailty Screening Is Associated with Reduction in the Rate of 1-year Mortality after Elective Operation 2020 ·Journal of the American College of Surgeons ·Patrick R. Varley, (unknown), (unknown), Nader N. Massarweh, Joel B. Nelson, Jonas T. Johnson, Jason M. Johanning, Daniel E. Hall	3
4	A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer 2019 ·Molecular Cancer Therapeutics ·Zhenyu Yang, Dan Wang, (unknown), Laura E. Pascal, (unknown), (unknown), Anish Bhaswanth Chakka, Jianhua Zhou, Wei Chen, (unknown), Qiong Song, Hui Ding, Zeyu Wu, Uma Chandran, (unknown), Joel B. Nelson, Peter Wipf, Zhou Wang	18
5	Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells 2018 ·Molecular Cancer Therapeutics ·Jun Dong, Zeyu Wu, Dan Wang, Laura E. Pascal, Joel B. Nelson, Peter Wipf, Zhou Wang	31
6	Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options breakdown → 2017 ·The Journal of Urology ·Martin G. Sanda, Jeffrey A. Cadeddu, Erin Kirkby, Ronald C. Chen, Tony Crispino, Joann Fontanarosa, Stephen J. Freedland, Kirsten L. Greene, Laurence Klotz, Danil V. Makarov, Joel B. Nelson, George Rodrigues, Howard M. Sandler, Mary Ellen Taplin, Jonathan Treadwell	583
7	Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells 2016 ·Assay and Drug Development Technologies ·Paul A. Johnston, Minh M. Nguyen, Javid A. Dar, Junkui Ai, Yujuan Wang, Khalid Z. Masoodi, Tongying Shun, Sunita Shinde, Daniel P. Camarco, Yun Hua, Donna M. Huryn, Gabriela Mustata Wilson, John S. Lazo, Joel B. Nelson, Peter Wipf, Zhou Wang	24
8	Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading 2016 ·Urology ·Timothy D. Lyon, (unknown), Jonathan G. Yabes, (unknown), Benjamin J. Davies, Bruce L. Jacobs, Joel B. Nelson	2
9	Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate 2011 ·The Prostate ·Jeffrey Tomaszewski, (unknown), Anil V. Parwani, Rajiv Dhir, Joel B. Mason, Joel B. Nelson, Dean J. Bacich, Denise S. O’Keefe	42
10	Chemopreventative Potential of the Cruciferous Vegetable Constituent Phenethyl Isothiocyanate in a Mouse Model of Prostate Cancer 2011 ·JNCI Journal of the National Cancer Institute ·Anna A. Powolny, Ajay Bommareddy, Eun‐Ryeong Hahm, Daniel P. Normolle, Jan H. Beumer, Joel B. Nelson, Shivendra V. Singh	87
11	Interaction of Integrin-Linked Kinase and Miniature Chromosome Maintenance 7–Mediating Integrin α7 Induced Cell Growth Suppression 2010 ·Cancer Research ·Yuchen Han, Yan Yu, Joel B. Nelson, Chuanyue Wu, Hui Wang, George K. Michalopoulos, Jianhua Luo	25
12	Multimodal analgesic approach incorporating paravertebral blocks for open radical retropubic prostatectomy: a randomized double-blind placebo-controlled study 2010 ·Canadian Journal of Anesthesia/Journal canadien d anesthésie ·Jacques E. Chelly, (unknown), Feng Dai, Joel B. Nelson	25
13	Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration‐resistant nonmetastatic prostate cancer 2010 ·Cancer ·Matthew R. Smith, Richard J. Cook, Ker‐Ai Lee, Joel B. Nelson	135
14	Glutathione Peroxidase 3, Deleted or Methylated in Prostate Cancer, Suppresses Prostate Cancer Growth and Metastasis 2007 ·Cancer Research ·Yan Yu, Guoying Yu, George C. Tseng, Kathleen Cieply, Joel B. Nelson, Marie C. DeFrances, Reza Zarnegar, George K. Michalopoulos, Jianhua Luo	190
15	Defining the basis of an operational model for enhanced efficacy of combination therapy using an endothelin receptor antagonist and chemotherapeutic agents 2007 ·Molecular Cancer Therapeutics ·Beth R. Pflug, (unknown), Jason M. D’Antonio, (unknown), Jon Curwen, Jim Growcott, Joel B. Nelson	5
16	Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer 2007 ·Annals of Internal Medicine ·Susan L. Greenspan, Joel B. Nelson, Donald L. Trump, Neil M. Resnick	19
17	Multimodal analgesia for radical prostatectomy provides better analgesia and shortens hospital stay 2007 ·Journal of Clinical Anesthesia ·Bruce Ben-David, (unknown), Joel B. Nelson, Jacques E. Chelly	23
18	Endothelin Receptor A Blockade Enhances Taxane Effects in Prostate Cancer 2006 ·Neoplasia ·Ardavan Akhavan, (unknown), Georgi Guruli, Robert R. Bies, William C. Zamboni, Sandra Strychor, Joel B. Nelson, Beth R. Pflug	37
19	Role of endothelin axis in progression to aggressive phenotype of prostate adenocarcinoma 2005 ·The Prostate ·(unknown), Grant W. Cannon, Glenn M. Cannon, Robert R. Bies, Joel B. Nelson, Beth R. Pflug	27
20	Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. 1996 ·PubMed ·Michael A. Carducci, Joel B. Nelson, Kirk M. Chan‐Tack, (unknown), (unknown), P A Campbell, William G. Nelson, Jonathan W. Simons	133

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact